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Dialysate protein losses with bleach processed polysuiphone dialyzers.
We measured dialysate protein losses from polysuiphone dialyzers under-
going repetitive processing with bleach and formaldehyde. The entire
dialysate was collected during the first, fifth and tenth use of F-80
dialyzers. Dialysate protein concentration was 1.5 0,4 mg/dl (N = 11,
5EM) during the first use, 2.1 0.3 mg/dI during the fifth use and 3.6 0.5
mg/dl (N = 10) during the tenth use. In a follow-up study, dialyzers were
evaluated for up to 25 uses. After 12 to 15 uses dialysate protein was 7.9
0.8 mg/dl (N = 13), after 16 to 20 uses; 12.0 1.2 mg/dl (N = 13) and
after 23 to 25 uses; 19.9 2.1 mg/dl (N = 5). Mean dialysate volume was
83.9 1.1 liters (N = 63) yielding total protein losses of up to 20.7 grams
per treatment. Dialysate albumin losses, which were unmeasurable during
the first use of the dialyzers, revealed a similar increase with reuse
resulting in a mean value of 14.4 3.2 mgldl after 23 to 25 reuses (N =
5). Dialysate beta-2 microglobulin (132m) levels were 1.05 0.13 mg/I for
dialyzers bleached <10 times (N = 32) versus 1.54 0.15 mg/liter for
dialyzers bleached >10 times (N = 31, P < 0.02 vs. <10 reuses). A random
sampling of dialyzers processed without bleach for 8, 14, 15, 24 and 25
reuses revealed minimal protein losses, ranging from 1.4 to 2.7 mgfdl with
no relation to reuse number and no measureable albumin. After determi-
nation of the bleach associated protein losses, bleach was removed from
the reprocessing procedure. Mean monthly serum albumin levels from all
44 patients dialyzed with the bleach reuse procedure increased from 3.55
0.01 g/dl (range 3.51 to 3.59) for the 6 months prior to discontinuing
bleach to 3.79 0.02 g/dI (range 3.77 to 3.89) for the first 6 full months
after bleach was removed (P < 0.001, bleach vs. no-bleach). We conclude
that repetitive bleach processing of polysulphone dialyzers increases
permeability and causes substantial protein losses. Protein losses are
reduced when bleach is removed from the reuse procedure. Removal of
bleach from the reuse procedure was associated with a substantial and
sustained increase in serum albumin levels.
Recent preliminary reports have indicated that serum albumin
levels decline with the initiation of high flux dialysis [1] and that
membrane permeability is enhanced as dialyzers are repeatedly
subjected to bleach reprocessing [2]. We performed a study to
determine if bleach processing induced a sufficient increase in
membrane permeability to account for substantial protein losses.
Polysuiphone membranes reprocessed with bleach and formalde-
hyde were tested for total protein leakage by collecting the
treatment's entire dialysate.
Methods
The study was conducted at the Dialysis Center of Newington,
a free-standing dialysis unit in Newington, Connecticut, USA.
Patients were dialyzed on Fresenius 3000E dialysis machines using
Fresenius F-80 polysuiphone dialyzers (Fresenius AG, Concord,
CA, USA). Of the eleven patients completing the study, the mean
age was 67 4 years with a range of 35 to 87 years. All patients
entering the study had stable serum albumin levels for three
months prior to the study. Mean serum albumin level at the
initiation of the study was 3.6 0.1 g/dl, with a range of 3.1 to 4.1
g/dl. Mean Kt/V for the initial treatments was 1.41 0.05.
Interdialytic weight gains averaged less than 3 kg. The study
protocol was approved by the Investigational Review Board of the
New Britain General Hospital. Informed consent was obtained
from all patients.
Sample collection
The entire volume of dialysate, from the initial activation of the
blood pump to the completion of the treatment, was collected in
55 gallon drum containers. Dialysate flow rate was set at 500
ml/min. At the end of the treatment the contents of the drum were
agitated and stirred, and an aliquot of 15 ml was withdrawn and
frozen within 24 hours. The entire drum was weighed and the
weight of the empty drum was subtracted from the weight of the
filled drum to determine total dialysate volume. Total dialysate
protein losses were calculated by multiplying the dialysate protein
concentration by the total volume of dialysate.
Sampling was scheduled during the first, fifth and tenth use of
each dialyzer. Following the completion of this protocol, dialyzers
from the same patients were studied for up to 25 reuses. Random
sampling for this follow-up study was dependent on continued
dialyzer integrity and the concurrent availability of the collection
apparatus and personnel. Dialysate sampling was subsequently
performed on five dialyzers reprocessed without bleach. These
dialyzers were chosen because they had attained a sufficient
number of reuses to allow comparison with bleach processed
dialyzers associated with substantial protein losses.
Dialyzer reprocessing
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Dialyzer reprocessing was performed with formaldehyde
(0.84%) and bleach using the Seratronics DRS-4 reprocessing
machine (Fresenius AG). Bleach concentration was at 0.5 to 0.8%
with dialyzer contact for seven minutes. Dialyzers studied after
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Table 1. Dialysate protein composition (mgldl) versus number of dialyzer uses
TP 1.1 1.5 3.2
132m 0.1 0.15 0.13
ALB 0.2 <0.2 1.2
UF (3.1) (2.7) (3.4)
TPL 1.0 1.4 2.9
PT 2:
6.2 5.2 2.7 13.2 9.5
0.21 0.12 0.17 0.24 0.22
3.6 1.9 2.0 7.9 7.6
(1.9) (1.7) (2.0) (2.2) (2.4)
5.1 4.4 2.4 11.8 9.0
TP 2.8 2.7 4.1
32m 0.01 0.03 0.14
ALB <0.2 0.2 0.8
UF (2.0) (0.9) NA
TPL 2.0 2.0 2.5
PT 3:
TP 0.1 2.5 5.1
32m 0.12 0.21 0.21
ALB <0.2 <0.2 1.6
UF (3.0) (3.1) (1.8)
TPL 0.1 2.0 4.0
PT 4:
TP 0.9 1.5 2.4
32m 0.01 0.1 0.2ALB <0.2 <0.2 0.2
UF (4.2) (1.9) (3.3)
TPL 0.8 1.3 2.2
PT 5:
TP 0.0 0.1 0.5
j32m 0.07 0.14 0.18ALB <0.2 0.3 0.2
UF (3.9) (3.8) (2.9)
TPL 0.0 0.1 0.3
PT 6:
TP 0.1 0.8 2.5
J32m 0.01 0.07 0.10ALB <0.2 0.2 0.5
UF (1.8) (2.4) (2.9)
TPL 0.1 0.6 2.0
PT 7:
TP 1.9 2.8 4.1
J32m 0.03 0.07 0.12ALB <0.2 0.2 0.4
UF (1.4) (2.8) (3.0)
TPL 1.5 2.4 3.3
PT 8:
TP 0.6 1.9 3.8
132m 0.01 0.01 0.09ALB <0.2 0.2 2.0
UF (1.8) (2.7) (2.5)
TPL 0.5 1.5 3.0
PT 9:
TP 2.5 2.8 5.1
f32m 0.23 0.27 0.14ALB <0.2 <0.2 0.5
UF (3.3) (2.7) (3.7)
TPL 2.2 2.7 5.1
PT 10:
TP 2.8 3.2 5.3
f32m 0.17 0.11 0.20
ALB <0.2 0.2 0.9
UF (1.1) (1.3) (1.6)
TPL 2.2 2.5 4.1
PT 11:
TP 3.2 3.2
/32m 0.03 0.07
ALB <0.2 2.0
UF (3.2) (4.5)
TPL 2.9 3.1
8.2
0.20
2.8
(2.8)
8.0
6.5
0.09
2.3
(2.5)
4.8
10.3 10.4
0.30 0.20
7.0 4.3
(2.9) (2.1)
7.8 8.0
8.2
0.15
5.9
(3.4)
7.1
8.3
0.11
6.5
(2.9)
7.1
8.2
0.11
10.7
(2.9)
7.2
12.4 5.9
0.05 0.11
3.5 4.6
(1.5) (0.7)
9.3 3.8
3.2
0.12
1.3
(1.6)
2.6
11.7
NA
NA
(2.4)
9.4
10.3 10.9
0.07 0.11
3.9 4.7
(2.5) (2.1)
9.4 9.9
15.2
0.07
12.1
(1.9)
12.4
10.2 14.0 18.0 16.4
NA 0.04 0.15 0.12
NA 3.3 5.9 12.0
(3.2) (3.8) (2.4) (2.8)
10.3 13.7 17.2 16.4
15.2
0.36
4.9
(3.2)
15.0
27.3
0.10
24.0
(4.0)
20.7
20.3 20.3
0.10 0.10
13.1 17.8
(2.3) (1.8)
16.2 19.0
Uses
1 / 5 / 10 / 12 13 14 15 16 17 / 19 20 / 23 24 25
PT 1:
16.5 17.0
0.24 0.35
5.2 10.1
(2.5) (2.7)
11.8 13.4
9.1 7.5
0.15 0.10
4.7 4.3
(3.2) (2.0)
6.2 5.9
NA
Abbreviations are: J32m, dialysate beta-2 microglobulin (converted to mg/dl); ALB, dialysate albumin (converted to mg/dl); UF, (net ultrafiltration),
L/treatment; TPL, total protein loss (g/treatment) = dialysate protein concentration X dialysate volume; NA, not available.
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the removal of bleach were processed with the same amount of
formaldehyde and in the same manner, but without the bleach
procedure.
Chemical analysis
All samples were evaluated for total protein using a pyrogallol
red-molybdenum microprotein assay (Alta Diagnostics, Laguna
Hills, CA, USA). All samples were measured in duplicate and the
values listed are the average of the two measurements. Chemical
determinations were performed in the Clinical Chemistry Labo-
ratory of the New Britain General Hospital. The intra-assay
coefficients of variation for this technique were 8.0%, 9.6% and
0.8% for standards of 6.25, 12.5 and 25 mg/dl, respectively. Each
of the dialysate samples was also analyzed for albumin by an
immunoprecipitin analysis used for microalbumin determinations
(Nichols Institute, San Juan Capistrano, CA, USA) and for beta-2
microglobulin by radioimmunoassay (Nichols Institute). The lim-
its of albumin detection was 0.2 mgldl. For purposes of statistical
analysis and graphic display, samples with unmeasurable albumin
levels (<0.2 mg/dl) were arbitrarily given a value of 0.1 mg/dl. All
serum albumin levels were determined by bromcresol green.
Statistical analysis
Regression analysis was performed on Sigma Plot software
(Jandel Scientific, Corte Madera, CA, USA). Comparison of
monthly serum albumin levels were by paired t-test comparing
each patient to his or her original value obtained during the time
of the original study (March). All values given are means
standard errors of the mean. The null hypothesis was rejected with
P < 0.05.
Results
Twelve patients were entered into the initial study protocol; one
patient dropped out due to intercurrent hospitalization. The
remaining eleven patients completed the initial protocol and ten
of these eleven contributed at least one sample to the follow-up
study. One dialyzer lost integrity prior to the 10th use (pt ii). Two
samples measured for total protein could not be matched with
albumin and beta-2 microglobulin values. Table 1 lists all values
for dialysate total protein concentration as obtained from dialyz-
ers being subjected to bleach reprocessing. Also listed are the
concomitant values for dialysate beta-2 microglobulin, dialysate
albumin, net volumes of ultrafiltration and the total dialysate
protein losses per treatment. The samples from the first use were
obtained from dialyzers that had not been bleach processed (dry
pack). During the first use, mean dialysate protein concentration
was 1.5 0.4 mgldl (N = 11), during the fifth use; 2.1 0.3 mgldl
(N = 11) and during the tenth use; 3.6 0.5 mgldl (N = 10). The
follow-up study demonstrated a mean dialysate protein concen-
tration of 7.9 0.8 mg/dl for filters used 12 to 15 times (N = 13),
12.0 1.2 mgJdl after 16 to 20 uses (N = 13) and 19.9 2.1 mg/dl
after 23 to 25 uses (N = 5). Figure 1 illustrates the relation of
dialysate protein concentration with the number of dialyzer uses
for both the initial and follow-up protocol. Best fit analysis
revealed a second order equation indicating that protein losses
were proportionately greater with increasing reuse (y = 1.24
0.Olx 0.03x2, r = 0.904, N = 63, P < 0.001).
Five filters reused without bleach were tested after 8, 14, 15, 24
and 25 uses. In contrast with the bleach reused dialyzers, dialysate
protein obtained from these dialyzers revealed no relation with
reuse, remaining between 1.4 and 2.7 mgldl. The mean dialysate
protein obtained from these filters (2.1 0.2 mgldl, N = 5) was
not significantly different from the mean value obtained from the
first use ("dry pack") of the dialyzers in the bleach reuse study
(1.5 0.4 mgldl, N = 11).
Total dialysate protein losses per treatment during bleach reuse
were calculated by multiplying the total dialysate volume by the
dialysate protein concentration, Mean total dialysate volume per
treatment was 83.9 1.1 liters (N = 63) with a range of 64 to 101
liters. Mean total protein losses per treatment were 1.2 0.3 g
during the first use, 1.8 0.3 g during the fifth use, 2.9 0.4 g
during the tenth use, 6.4 0.5 g during the twelfth through
fifteenth use, 10.4 1.1 g during the sixteenth through twentieth
use and 17.5 1.0 g during the twenty-third through twenty-fifth
use.
In order to further validate the results, dialysate samples were
also evaluated by an immunoprecipitin assay for albumin content
(Table 1). Dialysate albumin losses which were essentially unmea-
surable for the first and fifth use increased exponentially thereaf-
ter, attaining a mean 14.4 3.2 mg/dl after 23 to 25 reuses and
displaying a second order relation which was remarkably similar
to that of the total protein measurements (Fig. 2; y 0.27 — 0.17x
0.03x2, r = 0.818, N = 63, P < 0.001). In the 47 dialysate
samples with measurable albumin levels, the ratio of albumin to
total protein was 53%. Despite relatively high number of uses,
none of the dialysate samples from the non-bleached processed
dialyzers had detectable albumin levels (<0.2 mg/dl).
Dialysate f32m also increased with bleach reuse, but the relation
was not as impressive as that with either albumin or total protein
(Fig. 3). Much of the apparent scatter could be attributed to a
greater variation of values from patient to patient, most notably
during the initial use of the dialyzer when values ranged from
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Fig. 1. Relation between dialysate protein concentration and the number of
bleach processed dialyzer uses (y = 1.23 + 0.01x + 0.03x2, N = 63, r =
0.904, P <0.001).
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Fig. 2. Relation between the dialysate albumin concentration and the num-
ber of bleach processed dialyzer uses (y = 0.27 — 0.1 7x + 0.03x2, N = 63, r
= 0.818, P <0.001).
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0.1 mg/liter to 2.3 mg/liter (Table 1). When serial values were
evaluated for each patient, there was a positive correlation
between increasing f32m levels and reuse number in 10 of the 11
patients. When grouped together, mean dialysate 132m levels were
1.05 0.13 mg/liter for dialyzers reused <10 times (N = 32)
versus 1.54 0.15 mg/liter for dialyzers processed >10 times (N =
31, P < 0.02, >10 reuses vs. <10 reuses). Mean dialysate 2m for
the non-bleached dialyzers used for greater than 10 uses was 0.5
0.15 mg/liter (N = 4, P = 0.02 vs. bleach >10 reuses).
Pursuant to the determination of these substantial protein
losses, we elected to remove the bleach from our reprocessing
procedure. Mean monthly serum albumin levels from all 44
patients dialyzed with the bleach reuse procedure ranged from
3.51 0.04 to 3.59 0.05 g/dl for the six months prior to
discontinuing bleach, with no significant difference among the six
months (Fig. 4). Three weeks after discontinuing the bleach
procedure, serum albumin levels increased to 3.65 g/dl, with the
subsequent six months revealing values between 3.75 0.06 and
3.89 0.05 g/dl (P < 0.00 1 for bleach vs. no bleach by paired t-test
comparing each patients levels followed longitudinally for the 13
month period). Available mean monthly Kt/V values were 1.50
0.03 (N = 4) during the use of bleach and 1.43 0.04 (N = 7)
after bleach was removed (P = NS).
Discussion
preliminary report documenting a substantial increase in perme-
ability as a result of progressive reprocessing with bleach [2]. This
observation prompted us to determine the amount of protein loss
in bleach processed polysulphone dialyzers. Our original protocol
was a longitudinal study of the same dialyzer studied for up to 10
uses. The steadily increasing tendency to leak protein as dialyzer
reuse increased (Table 1) prompted a follow-up investigation of
protein leakage from more extensively used dialyzers.
Considering the increasing propensity of dialyzers to lose
integrity with increased reuse and the unlikely possibility that all
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Fig. 4. Mean semm albumin levels for 44 patients who had been dialyzed for
at least one month on bleach processed dialyzers. Bleach was removed from
the reuse procedure 3 weeks prior to the June values. When compared by
paired t-test, all values from June to December were significantly in-
0 5 10 15 20 25 creased when compared to the values obtained during the use of bleach(P < 0.001).
Number of dialyzer uses
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Despite general agreement on the importance of nutritional
I I I parameters as predictors of dialysis related mortality [3, 4] there
0 5 10 15 20 25 are limited published data regarding the protein sieving charac-
teristics of reused dialyzers [5—7]. Of particular interest was a
Number of dialyzer uses
Fig. 3. Relation between dialysate concentrations of beta-2 microglobulin
and the number of bleach processed dialyzer uses (y = 0.88 + 0.04s N = 63,
r = 0.323, P <0.02).
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dialyzers would remain clinically usable for a prolonged longitu-
dinal study, we elected to study dialyzers which had already
maintained integrity for a substantial number of treatments.
Despite this random selection of dialyzers, measurements of
dialysate protein demonstrated a close relation between increas-
ing protein loss and the number of bleach processings (Fig. 1,
Table 1). Despite previous data demonstrating that protein losses
are greatest during the convective transport associated with net
ultrafiltration [8], there was no relation between the net ultrafil-
tration per treatment and protein losses (Table 1), suggesting that
progressively increasing permeability was an overiding factor.
The nature of the protein loss was investigated by two deter-
minations, one for albumin and the second for 2m. In general,
the percentage of total protein losses represented by albumin was
essentially unmeasurable for the first and fifth uses and increased
progressively thereafter, averaging 53% for all 47 samples with
measurable values by the immunoprecipitin method (>0.2 mg/dl).
The relation of albumin losses with increasing numbers of reuse
was remarkably similar to that for total protein and substantiates
an overall increase in large molecular weight sieving (Fig. 1, 2).
Although statistically significant, the relationship between the
number of reuses and f32m was weak when compared to that for
total protein or albumin (Fig. 3). This discrepancy probably
reflects several factors including a less accurate measurement
technique and what was likely a greater variability in the patients'
serum levels, which were not measured. In this regard, it is well
established that $32m levels vary greatly among dialysis patients,
ranging from 17 to 69 mg/liter [5, 9, 10] a much greater range of
variability than for the serum albumin levels measured in our
patients at the initiation of the study (3.1 to 4.1 g/dl). In
agreement with this explanation is that values listed on Table 1
clearly demonstrate a marked degree of variability in dialysate
132m levels which were evident even during the first use of each
dialyzer (range 0.01 to 0.23 mg/dl). Furthermore, regression
analysis of the dialysate f32m levels from each individual revealed
a positive relation between increasing dialysate )32m and reuse in
all but one of eleven patients.
Despite the confounding factors mentioned above, there was
still a statistically significant 50% increase in dialysate j32m from
dialyzers bleached more than 10 times versus those bleached for
10 times or less (1.05 vs. 1.54 mg/liter, P = 0.02). This result
suggests an alternative explanation for the decreasing serum levels
of 2m which have been reported when dialyzers are extensively
reprocessed with bleach [11]. Whereas the authors of that report
suggested that increased adsorption was responsible for decreas-
ing serum levels, our data demonstrate a substantial increase in
dialyzer permeability as a more plausible explanation. This in-
creased permeability may also explain some of the discordance
reported in the serum levels of 132m microglobulin during appar-
ently similar prescriptions of high flux dialysis, in that lower values
have been noted with bleach reprocessing [7] than without [12].
It would be erroneous to conclude from our data that all reuse
procedures are likely to increase protein sieving. In fact, at least
two studies of reuse with peracetic acid demonstrate a decrease in
protein sieving with increasing numbers of reuse [5, 6]. Thus,
extrapolation of our data to different reuse procedures and
different membranes would be inappropriate.
It should be noted that dialysate amino acid losses were not
measured and estimates for these losses should be added to the
measured total protein losses as detailed on Table 1. Previous
studies of amino acid losses during dialysis with particularly
"tight" cuprophane dialyzers found an approximate 8 gram loss
per treatment [13, 14]. Considering the increased permeability of
high flux polysulphone dialyzers for molecules in the general size
range of amino acids (approximately 150 daltons), enhanced
amino acid loss would be expected even without the increased
permeability resulting from bleach processing. Thus, it is not
surprising that the currently available preliminary data suggests
that amino acid losses are approximately 30 to 50% higher during
high flux dialysis, even without reuse [15—17]. Considering all the
available evidence, it is our conclusion that net amino acid losses
would be approximately 12 grams per treatment. Furthermore,
since unused high flux dialyzers are already extremely permeable
to molecules of their size, amino acid losses would not change
appreciably as a result of bleach processing.
Subsequent to obtaining the results of our measurements, we
felt it prudent to remove bleach from our reprocessing procedure.
The statistically significant increase in serum albumin levels after
removal of bleach (3.55 g/dl to 3.79 g/dl) compelled us to
document that our new reuse procedure did indeed minimize
dialysate protein losses. The finding that highly used non-bleached
dialyzers produced dialysate with uniformly unmeasurable albu-
min levels and very modest levels of total protein provides
significant support for the conclusion that it was the bleach which
was responsible for increasing dialyzer permeability and substan-
tial protein losses. The significant increases in serum albumin
levels noted after removal of bleach suggests that bleach associ-
ated protein losses were responsible for the apparently depressed
albumin levels. Nonetheless, our study does not allow definitive
conclusions regarding cause and effect between lowered serum
albumin levels and bleach reuse, and further study on this issue is
clearly warranted. In any event, the substantial increases in serum
albumin levels observed after removal of bleach must be consid-
ered in the context of mounting evidence that even small changes
in serum albumin levels are strong predictors of mortality in
dialysis patients [3, 18].
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